Sign inJoin waitlistJoin the waitlist

Lucie Turcotte

Director, Division of Pediatric Hematology/Oncology · University of Minnesota

Credentials: · · · · ·

History

University of Minnesota
Present

Hematology and Medical Oncology
2010–2013
Internal Medicine
University of Washington School of Medicine
2007–2010
University of Minnesota Medical School
2003–2007

Research

Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015
JAMA · 2017 · First of 14 authors · 193 citations
Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review
Review · Journal of Clinical Oncology · 2018 · First of 10 authors · 112 citations
Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease
Pediatric Blood & Cancer · 2014 · 98 citations

Greg Armstrong
48 papers
Joseph Neglia
48 papers
Kevin Oeffinger
24 papers
TH
Tara Henderson
19 papers
Melissa Hudson
15 papers
Smita Bhatia
13 papers · 3 as a fellow
Miriam Conces
10 papers
Alex Hoover
7 papers · 6 as a fellow
Anne Blaes
7 papers
Matthew Ehrhardt
7 papers
Michael Verneris
7 papers
SC
Stephen Chanock
7 papers

Grants

Socioeconomic and Adversity-Associated Immunobiologic Influences on Pediatric Hematopoietic Cell Transplant Outcomes
National Cancer Institute · R01
Contact PI · $1.3M · University of Minnesota
2025–2030
(PQ2) Donor Socioeconomic Status as a Predictor of Altered Immune Function and Treatment Response Following Hematopoietic Cell Transplantation for Hematologic Malignancy
National Cancer Institute · R01
PI · $1.5M · Medical College of Wisconsin
2019–2024
Treatment Modifications, Outcomes and Provider Decision Making in the Management of Subsequent Breast Cancers Among Survivors of Childhood Cancer
National Cancer Institute · K08
Contact PI · $714.1K · University of Minnesota
2018–2023